Black patients with atrial fibrillation are less likely to be prescribed newer anticoagulant medications when they leave the hospital compared to their white counterparts and are consequently more likely to experience adverse ...
Oct 27, 2022
0
58
COVID-19 infection is linked to a subsequent heightened risk of poor cardiovascular health and death, particularly among those whose infection is severe enough to require hospital admission, finds a large UK Biobank study, ...
Oct 24, 2022
0
128
Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.
Oct 11, 2022
0
808
Researchers at Mayo Clinic have used artificial intelligence (AI) to evaluate patients' electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation, a common heart rhythm disorder. Atrial fibrillation ...
Sep 28, 2022
0
63
If you're already taking one blood thinner, mounting research suggests you might not need to take a second one.
Sep 19, 2022
0
84
Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than women; but it has never been fully understood why women would be protected from developing the condition. New research from ...
Aug 31, 2022
0
69
Many ethnic minority patients in England with the most common form of atrial fibrillation (AF) are not being prescribed the blood thinners they need to lower their stroke risk, according to data scientists at the University ...
Jun 7, 2022
0
48
There are racial and socioeconomic inequalities in the prescribing of oral anticoagulants to reduce stroke risk in people with atrial fibrillation, according to a new study conducted in the UK and publishing June 7 in the ...
Jun 7, 2022
0
36
Combination chemoimmunotherapy with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for previously untreated mantle cell lymphoma (MCL) ...
Jun 3, 2022
0
35
Research from the Yale School of Medicine indicates that a protein kinase that is a master regulator of cell metabolism is critical to preventing atrial fibrillation. The research appeared April 22 in the journal JCI Insight.
Apr 26, 2022
0
42
